Home › Funds › PSP Research LLC › EXEL

PSP Research LLC position in EXEL

EXELIXIS INC · Health Care

PSP Research LLC reported holding 5,000 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$292K, representing 0.20% of its reported portfolio and ranking #6 among its reported holdings. PSP Research LLC has disclosed EXEL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)5.00K sh
Reported value held$292.05K
Portfolio Weight0.20%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's EXEL position evolved

PSP Research LLC first disclosed a stake in EXEL in Q4 2025 at 11,948 shares (US$524K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,000 shares valued at US$292K — a reduction of -3,000 shares quarter over quarter.. Notable position changes include a 33% trim in Q2 2026 (shares rose 6% over the following quarter), a 38% trim in Q3 2026 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 11.95K $523.68K New
Q1 2026 11.95K $512.45K Hold
Q2 2026 8.00K $435.28K Reduce
Q3 2026 5.00K $292.05K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 42 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M), Renaissance Technologies (US$730.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has PSP Research LLC held EXEL?

PSP Research LLC has disclosed EXEL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in EXEL?

As of Q3 2026, PSP Research LLC holds 5.00K shares of EXEL (EXELIXIS INC), valued at $292.05K, representing 0.20% of its reported portfolio and ranking #6.

Has PSP Research LLC been buying or selling EXEL?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in EXEL.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.